Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells by Foreman, K. E. et al.
Inflammation, Vol. 20, No. 1, 1996 
C O M P A R A T I V E  E F F E C T  O F  C 3 a  A N D  C 5 a  O N  
A D H E S I O N  M O L E C U L E  E X P R E S S I O N  O N  
N E U T R O P H I L S  A N D  E N D O T H E L I A L  C E L L S  
K. E. FOREMAN, 1"2 M. M. GLOVSKY, 3 R. L. WARNER, 1 
S. J. HORVATH, 4 and P. A. WARD 1 
I University of Michigan, 
Department of Pathology, 
Ann Arbor, Michigan 
2Parke-Davis Research 
Division of Warner-Lambert Company, 
Ann Arbor, Michigan 
3Huntington Memorial Hospital, 
Asthma and Allergy Center, 
Pasadena, California 
4 Caltech 
Beckman Institute, Pasadena, California 
Abstract--Complement activation is known to enhance neutrophil binding to human 
umbilical vein endothelial cells (HUVECs). Recently, we have shown that recom- 
binant human C5a upregulates P-selectin in HUVECs. Unstimulated human neutro- 
phil binding is also increased on C5a stimulated HUVECs. We demonstrate in this 
report that C5a upregulates CD1 lb/CD18 in human neutrophils. Also shown is that 
synthetic C3a57_77 and an analog 15 amino acid C3a peptide (C3ats) neither upregulate 
CD1 lb/CD18 nor do the C3a peptides increase P-selectin, ICAM-1 or E-selectin in 
HUVECs. Thus C5a and not C3a is responsible for early ( -  30 minutes) neutrophil 
adhesion to endothelial cells after complement activation. 
INTRODUCTION 
The human complement derived anaphylatoxins C3a and C5a are structurally 
related peptides released from the c~-chain of C3 and C5 during complement 
activation via the classical or the alternative pathway (1). These multifunctional 
peptides have been shown to possess similar biological activities and effect a 
wide variety of cells and tissues involved in acute inflammation. Among their 
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numerous biological effects, both C3a and C5a induce neutrophil aggregation, 
lysosomal enzyme release from human neutrophils and increase vascular perme- 
ability to the skin (2). C5a is also chemotactic for neutrophils in human skin 
and enhances neutrophil accumulation in lung vessels. It is known that C5a is 
approximately 100-fold more active in most assay systems than C3a (2). How- 
ever, the plasma concentration of C3a is 15-fold greater than that of C5a (70 
/~g/ml compared with 4.9/xg/ml),  and this higher concentration may help com- 
pensate for the lower functional activity of C3a (2). 
Recent studies from our laboratory and others have indicated that comple- 
ment cleavage products, including C5a, may be involved in leukocyte adhesion 
to endothelial cells, a process which is recognized as one of the first critical 
steps in neutrophil migration into an area of inflammation. In vitro studies have 
demonstrated C5a upregulation of CD1 lb/CD18 receptor expression on neutro- 
phils (3-5). C5a upregulates P-selectin expression on human umbilical vein 
endothelial cells (HUVECs) resulting in increase adhesion of unstimulated neu- 
trophils to the endothelial cells (6). Deposition of sublytic concentrations of 
C5b-C9 (membrane attack complex) and also been shown to upregulate endo- 
thelial cell P-selectin expression resulting in neutrophil adhesion (7, K. S. Kil- 
gore personal communication). The studies presented here were designed to 
compare the effect of C3a and C5a on both endothelial cell and neutrophil 
adhesion molecule expression. 
M E T H O D S  
Chemicals and Reagents. Recombinant human C5a was a gift of Dr. Henry Showell (Pfizer 
Central Research, Groton, Connectuicut). The ED50 for the chemotactic activity of this C5a prep- 
aration was 1-5 nM (6). The C3a peptides, C3a57_77 , as  potent as native C3a (8), and C3al5 an 
analogue peptide with the stmcture Trp-Trp-Gly-Lys-Lys-Tyr-Arg-Ala-Ser-Lys-Leu-Gly-Leu-Ala- 
Arg was found to be 12-15 times more potent than native C3a (9). C3a~5 has been altered with the 
italicized amino acids from the native C3a63_77. Both were synthesized by solid phase automated 
chemistry (Applied Biosystems) and were purified by HPLC or by Sephadex chromatography. 
Structures of the C3a peptides were confirmed by amino acid analysis. Functional activity of the 
peptides was demonstrated by a >700% increase in permeability of radioiodinated BSA into rat 
skin injected intradermally with the C3a peptides. Murine monoclonal antibody against human 
P-selectin (PNB1.6) was the gift of Dr. James C. Paulson (Cytel Corporation, San Diego, Cali- 
fornia). Monoclonal antibody to human CD18 was provided by Dr. C. Wayne Smith (Baylor 
University, Houston, Texas). The human anti-E-selectin monoclonal antibody (CL3) has been pre- 
viously described (10). Anti-ICAM-1 antibody was obtained from Research and Diagnostic Systems 
(Minneapolis, Minnesota). Recombinant human TNFc~ was obtained from Peprotech (Rocky Hill, 
New Jersey). The 2', 7'-bis-(2-carboxyethyl)-5 (and -6) -carboxyfluorescein, acetoxymethyl (BCECF- 
AM) used for fluorescent labeling of neutrophils was purchased from Molecular Probes (Eugene, 
Oregon). Other reagents were obtained from Sigma (St. Louis, Missouri). 
Endothelial Cell Preparation. HUVECs were isolated by collagenase treatment of freshly 
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obtained human umbilical cords and plated on gelatin-coated tissue culture dishes (Falcon Co., 
Lincoln Park, New Jersey) (11). Dulbecco's modified Eagle's media with Ham's F-12 and 20% 
heat inactivated fetal bovine serum (FBS) supplemented with 2 mM L-glutamine, 100 units/ml 
penicillin, 100 ~g/ml streptomycin, 0.25 /~g/ml Fungizone, 25 t~g/ml endothelial cell growth sup- 
plement (Collaborative Research, Bedford, Massachusetts), and 15 units/ml bovine heparin was 
used to maintain the ceils. HUVECs were used between the first and third passage and were 
characterized by a cobblestone appearance and specific staining for von Willebrand factor. 
Preparation of Neutrophils. Whole blood was obtained from healthy human volunteers and 
anticoagulated with citrate dextrose solution. Neutrophils were isolated by gradient centrifugation 
over Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) followed by 1% dextran sedimentation for 1 
hr to separate neutrophils from erythrocytes. Remaining erythrocytes were removed by hypotonic 
lysis and the neutrophils washed twice in Hanks' balance salt solution containing 0.1% bovine 
semm albumin (HBSS-BSA). Cells were resuspended to 5 • 10 6 cells/ml in HBSS-BSA and prep- 
arations contained > 95 % neutrophils. 
Fluorescent Labeling of Neutrophils. Fifty tzg aliquots of BCECF-AM were freshly dis- 
solved in 50/zl dimethyl sulfoxide. This was added to the neutrophil suspension at a final concen- 
tration of 1 mM BCECF-AM. The mixture was incubated for 30 min at 37~ and then the cells 
were washed twice with 4~ HBSS-BSA. The cells were resuspended in HUVEC media at 1 • 
10 6 cells/ml for use in the adhesion assay. 
Assay of Neutrophil Adherence to HUVEC Monolayers. An assay for measuring static 
adhesion of fluorescent labeled neutrophils to HUVEC monolayers has been recently described (12). 
Briefly, HUVECs were plated at 5 • 104 cells/well in 96-well flat-bottom fibronectin-coated plates 
and grown to confluence at 37~ with 5% CO2. The cells were washed twice with fresh HUVEC 
media and stimulated as described in the text at 37~ with 5% CO2. The cells were washed twice 
with warm media and 1 • 105 fluorescent-labeled neutrophils added to each well. A standard curve 
relating cell number to fluorescence was prepared on each plate by performing two fold serial dilution 
of the neutrophils from 1 • 105 to 6.25 x 103 cells/well. Microtiter plates were incubated 30 min 
at 37~ with 5% CO2. The non-adherent neutrophils were then removed with gentle washing. 
Remaining fluorescence was measured with a Cytofluor 2300 Fluorescence Measurement System 
(Millipore, Bedford, Massachusetts) using an excitation filter at 485 nm and emission filter at 530 
nM. 
ELISA for Adhesion Molecule Expression. An ELISA to determine adhesion molecule 
expression on endothelial cells was developed in this laboratory (13). Briefly, HUVECs were plated 
at 5 • 104 cells/wells in 96-well flat-bottom fibronectin-coated plates and grown to confluence at 
37~ with 5% CO2. The cells were washed with warm HUVEC media and stimulated as described 
in the text at 37~ Following stimulation, the endothelial cell monolayers were washed and fixed 
with 1% paraformaldehyde. 5% non-fat dry milk was used to reduce nonspecific binding and the 
cells incubated with primary antibody (1/~g/ml) for 45 min. The cells were washed and a peroxidase- 
conjugated rabbit anti-mouse IgG (Dako Corporation, Carpinteria, Califomia) was added for 40 
min. After washing, the substrate (o-phenylenediamine dihydrochloride) was added for 30 min and 
the reaction quenched with 3M sulfuric acid. Optical density was determined at 490 nm using an 
automated microplate reader (EL340, Bio-Tek Instruments, Winooski, Vermont). 
Flow Cytometry for Adhesion Molecule Expression. Rat and human peripheral neutrophils 
were analyzed for a change in expression of CD1 lb and CD18 surface molecules by immunoflu- 
orescence flow cytometry. Purified neutrophils were stimulated for 15 min at room temperature with 
either C5a or C3a, and PMA was used as a positive control with unstimulated cells as a negative 
control. Cells were then washed and stained with murine monoclonal antibodies specific for the 
desired adhesion molecules (for rat neutrophils: IB6c, CD1 lb; WT-1, CD18; for human neutrophils: 
mAB17, CDllb;  CL-26, CD18), followed by phyocerythrin labeled anti-mouse IgG as the sec- 
ondary antibody (AMAC, Inc., Westland, Maine). The isotype matched control consisted of ceils 
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stained with MOPC-21 (mouse IgG) and phyocerythrin labeled secondary antibody. Monoclonal 
antibody binding of gated neutrophil populations (identified by forward vs. right angle scatter 
characteristics) were measured on a FACScan Flow Cytometry System (Becton Dickinson, San 
Jose, California) in which 10,000 cells per determination were counted and the extent of binding 
was analyzed using PC-LYSYS software (Becton Dickinson). 
Statistical Analysis. Each ELISA and cell adhesion assay experiment contained 4-6 repli- 
cates and was repeated 2-3 times with similar results. Each datapoint represents the mean from a 
representative experiment + the standard error of the mean. Statistical differences between groups 
were measured by analysis of variance. 
R E S U L T S  
Roles of C5a and C3a Peptides in Endothelial Cell Adhesion Molecule 
Expression. As the  C 3 a  pept ides ,  C3a57_77 and  C3a15, h a v e  b e e n  s h o w n  to b e  
as or  more  ac t ive  than  na t ive  C3a1_77 in b io log ica l  sys tems  (9), we  s tudied the i r  
effect on  adhes ion  mo lecu l e  expres s ion  on  H U V E C s .  H U V E C s  were  incuba ted  
for  2 h r  (for  de tec t ion  o f  E-se lec t in  and  I C A M - 1 )  or  10 m i n  (for  de tec t ion  o f  
P-select• wi th  5 0 / ~ M  C3a55_77 , 50 # M  C3als ,  or  250  n M  C5a.  Twen ty - f ive  
n g / m l  TNFet  or  5 m M  h i s t amine  was  used  as a pos i t ive  cont ro l  and  H U V E C  
med ia  was used  for  a nega t ive  control ,  T he  resul ts  d e m o n s t r a t e d  the  expec ted  
increase  in E-se lec t in  and  I C A M - 1  exp re s s ion  wi th  TNFc~ s t imula t ion ;  howeve r ,  
there  was  no  increase  in expres s ion  o f  e i the r  adhes ion  molecu le  on  H U V E C s  
incuba ted  wi th  C3a57_77 or  C3a~5 (Tab le  1). S t imula t ion  o f  the  cells  wi th  250  
n M  C5a  or  5 m M  h i s t a m i n e  resul ted  in the  expec t ed  up regu la t ion  o f  P-se lec t in  
in the endothe l ia l  cel ls  wh i l e  C3a57_77 and  C3al5 d id  not  resul t  in express ion  
above  basa l  levels  (Tab le  1). 
Table 1, Adhesion Molecule Expression on HUVECs ~ 
Adhesion molecule expression (optical density at 490 nm) 
Stimulus 
added E-selectin ICAM- 1 P-selectin 
None 0.614 +_ 0.018 1.447 ___ 0.017 0.749 + 0.011 
TNF~ 2.174 + 0.064 b 2.431 • 0.025 t' 0.734 + 0.003 
Histamine 0.625 + 0.014 1.435 • 0.029 0.851 + 0.026 b 
C5a 0.608 • 0.016 1.447 • 0.031 0.816 + 0.012 b 
C3als 0.604 + 0.019 1.477 5:0.020 0.721 + 0.020 
C3a57_77 0.604 + 0.031 1.459 • 0.045 0.732 • 0.024 
"5 • 104 HUVECs were incubated with indicated stimulus for 2 hours (E-selectin and ICAM-1 
expression) or 10 minutes (P-selectin expression) with TNF (25ng/ml), histamine (5mM), C5a 
(250nM), C3a15 (100~tg/ml) or C3a57_77 (100#g/ml). Adhesion molecule expression was determined 
using a cell-based ELISA assay as described. 
bp-value <0.05 as compared to absence of stimulus. 
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Fig. l .  Neutrophil binding to HUVECs incubated for 10 minutes at 37 ~ with 1-100 #g/ml 
C3a57_77 or C3a15 was not increased over background levels. However, incubation of the endothelial 
cells with 250 nM C5a did increase neutrophil binding 6-fold above baseline levels. 
Effects of  C3a and C5a Treatment of  HUVECs on Neutrophil Adher- 
ence. Endothelial cells were incubated with a 1-100 /~g/ml (0.5-50 /zM) 
C3a57_77 and C3a15 for 10 min. The HUVECS were then washed and fluores- 
cently labeled neutrophils added. No difference in neutrophil binding to the 
endothelial cells was seen with C3a stimulated HUVECs as compared to un- 
stimulated controls (Fig. 1). In contrast, incubation of the HUVECs with 250 
nM C5a for 10 min resulted in a six-fold increase in neutrophil adherence, as 
expected. 
CDl l b/CD18 Receptor Expression on Neutrophils Incubated with C5a and 
C3a Peptides. Incubation of C3a15 o r  C3a57_77 (50 #g/ml) with human neutro- 
phils for 15 min showed no significant upregulation of either CD1 lb or CD18 
as measured by flow cytometry. However, incubation of the neutrophils with 
either C5a (250 nM) or PMA (100 ng/ml) upregulated both CD1 lb and CD18 
(Table 2). 
DISCUSSION 
Previous studies from our laboratory and others indicate complement may 
play an important role in neutrophil migration into areas of inflammation. Using 
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Table 2. CD1 lb and CD18 Expression on Neutrophils" 
Percent increase in expression 
Stimulus 
added CD1 lb CD18 
PMA 195% 156% 
C5a 134 % 145 % 
C3al5 -20% -27% 
C3a57_77 -28% - 16% 
"Neutrophils were incubated for 15 minutes at room temperature 
with PMA (100ng/ml), C5a (250riM), or C3a~5 (50/~g/ml) or 
C3a57 77 (50/zg/ml). CDllb and CD18 expression were deter- 
mined using flow cytometry as described. Results are expressed 
as percent increase over baseline levels of expression. Negative 
results indicate a decrease in mean standard fluorescence. 
a hybrid molecule of  the complement activator cobra venom factor linked to the 
endothelial binding lectin Ulex europaeus 1 (ULEX-CVF),  Marks et al. dem- 
onstrated that in the presence of  serum, ULEX-CVF rapidly activated comple- 
ment resulting in complement fixation on the endothelial cell surface (14). Under 
the experimental conditions, iC3b, C5 and membrane attack complex were 
deposited on the cells, and the complement fixation resulted in rapid and potent 
adhesion of  unstimulated neutrophils to the endothelial cells. This adhesion was 
mediated by the iC3b receptor (CD1 lb /CD18,  CR3) as anti-CD1 lb  or CD18 
antibodies inhibited neutrophil binding to the endothelium by 65-89%,  and C3 
deposition was demonstrated to be critical for the observed increase in adhesion 
(14). 
Involvement of  the C5a in adhesion molecule expression and function has 
been demonstrated. Using recombinant C5a, we have previously demonstrated 
that C5a upregulated P-selectin in a time and dose-dependent manner (16). This 
increase in P-selectin expression was accompanied by a rapid increase in adher- 
ence of  unstimulated neutrophils to the stimulated endothelial cells (6). Maximal  
neutrophil binding peaks at 10 min and returns to baseline at 30 min which 
coincides with the time course of  P-selectin expression. C5a did not increase 
E-selectin expression on the endothelial cells when the incubation with 250 nM 
C5a was increased to 2 hr (6). In the present study, C3a peptides, C3a57_77 and 
C3a15 neither upregulated P-selectin, E-selectin, or ICAM-1 (Table 1), nor 
increased neutrophil binding to HUVECs (Figure 1). The results indicate that 
C3a does not play a direct role in upregulation of  endothelial cell P-selectin; 
however, C3a and C5a are known to induce histamine release (15) which is 
known to upregulate P-selectin on endothelial cells. Therefore, C3a may have 
an indirect effect on P-selectin expression. 
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The importance of complement and adhesion molecule expression has also 
been demonstrated in vivo. Intravenous injection of cobra venom factor into rats 
results in the development of acute lung injury which is neutrophil dependent 
and oxygen radical mediated. The injury in this model is measured by increases 
in lung vascular permeability as measured by leakage of radioiodinated BSA 
and chromium-labeled red blood cells into the lungs. Monoclonal antibodies 
directed against CDl lb ,  CD18, ICAM 1, or P-selectin protect the lungs from 
damage by decreasing the permeability index 51-69 % and the hemorrhage index 
48-75% (16-18). Similar reductions in the neutrophil content of the lungs as 
measured by myeloperoxidase content were also found. 
Adherence of neutrophils to endothelial cells is an essential step in migra- 
tion of these inflammatory cells to the lung and skin. From the experimental 
evidence provided by our laboratory and others, we propose that complement 
may be an essential component in neutrophil adhesion to endothelial cells (Fig. 
2). This evidence indicates that C5a plays a keyrole as this anaphylatoxin has 
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Fig. 2. Proposed involvement of complement activation products in the regulation of neutrophil 
adhesion to endothelial cells. 
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been shown to upregula te  both  neutrophi l  ( C D l l b / C D 1 8 )  and endothel ia l  cell  
(P-select in)  adhes ion-p romot ing  molecu les .  C3a; however ,  appears  to be o f  
lesser  impor tance ,  i f  any,  in early neutrophi l  adherence  to endothel ium.  The 
membrane  attack complex  (C5b-C9)  in sublytic  concent ra t ions  is also k n o w n  to 
upregulate P-se lec t in  (7). In addi t ion,  the depos i t ion  o f  C3b and iC3b on the 
endothel ial  cell  surface during c o m p l e m e n t  act ivat ion may  also enhance  neutro-  
phil b inding to the endothel ia l  cells.  
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